Evidence map›Paper›PMID 30977021›Full record

ArticleInternational urology and nephrology2019

Long-term oncological outcomes of cystic renal cell carcinoma according to the Bosniak classification.

R Boissier, I Ouzaid, F X Nouhaud, Z Khene, C Dariane, S Chkir, S Chelly, A Giwerc, C Allenet, J B Lefrancq and 12 more

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in International urology and nephrology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Imaging Characterization of Renal Masses.Medicina (Kaunas, Lithuania) · 2021
    Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

R BoissierDepartment of Urology and Kidney Transplantation, Conception Academic Hospital, Aix-Marseille University, 13005, Marseille, France. Romain.Boissier@ap-hm.fr.
I OuzaidUrology Department, Bichat-Claude-Bernard, Paris, France.
F X NouhaudUrology Department, Rouen University Hospital, Rouen, France.
Z KheneUrology Department, Rennes University Hospital, Rennes, France.
C DarianeUrology Department, Georges Pompidou University Hospital, Paris, France.
S ChkirDepartment of Urology and Kidney Transplantation, Conception Academic Hospital, Aix-Marseille University, 13005, Marseille, France.
S ChellyUrology Department, Angers University Hospital, Angers, France.
A GiwercUrology Department, Rouen University Hospital, Rouen, France.
C AllenetUrology Department, Bordeaux University Hospital, Bordeaux, France.
J B LefrancqUrology Department, Grenoble University Hospital, La Tronche, France.
P GimelUrology Department, Medipole, Cabestany, France.
T BodinUrology Department, Saint-Joseph Hospital, Marseille, France.
N Rioux-LeclercqPathology Department, Rennes University Hospital, Rennes, France.
J M CorreasRadiology Department, Georges Pompidou University Hospital, Paris, France.
L AlbigesOncology Department, Gustave Roussy Institute, Paris, France.
J F HetetUrology Department, Clinique Jules Verne, Nantes, France.
P BigotUrology Department, Angers University Hospital, Angers, France.
J C BernhardUrology Department, Bordeaux University Hospital, Bordeaux, France.
J A LongUrology Department, Grenoble University Hospital, La Tronche, France.
A MejeanUrology Department, Georges Pompidou University Hospital, Paris, France.
K BensalahUrology Department, Rennes University Hospital, Rennes, France.
AFU Committee of Urological Oncology

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo evaluate the prognostic role of the Bosniak classification on the long-term oncological outcomes of cystic renal cell carcinomas. MATERIAL AND

methodIn a national multicentric retrospective study, we included patients treated surgically for localized cystic RCC from 2000 to 2010. Patients with a follow-up of less than 4 years, benign tumors, and ablative treatments were excluded. The primary outcome was disease-free survival.

results152 patients met the inclusion criteria: Bosniak II (6%), III (53%), IV (41%), with a median follow-up of 61 (12-179) months. Characteristics of the population and the tumors were [median, (min-max)] age 57 (25-84) years old, tumor size 43 mm (20-280), RENAL score 7 (4-12), PADUA score 8 (5-14). Treatments were 55% partial nephrectomy, 45% radical nephrectomy, 74% open surgery, and 26% laparoscopy. In pathological report, cystic RCC were mainly of low grade (1-2, 77%) and low stage (pT1, 81%). The two main histological subtypes were conventional (56%) and papillary (23%) RCC. Staging at presentation and histological characteristics were similar between Bosniak III and IV, except for high grade which was more common in Bosniak IV (12 vs 36%, p < 0.01). The Bosniak classification was not predictive of the recurrence, as 5- and 10-year disease-free survival were similar in Bosniak III and IV (92% vs 92% and 84% vs 83%, p = 0.60).

conclusionThe Bosniak classification is predictive of the risk of malignancy but not of the oncological prognosis. Regardless of the initial Bosniak categories, almost all cystic RCCs were of low stage/grade and had low long-term recurrence rate.

Indexed as

NephrectomyAdultAgedAged, 80 and overCarcinoma, Renal CellDisease-Free SurvivalFemaleHumansKidney NeoplasmsMaleMiddle AgedPrognosisRetrospective StudiesTime FactorsTreatment OutcomeBosniakComplex renal cystRenal cell carcinoma

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.